Summit Global Investments’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
608
+1
+0.2% +$423 0.01% 494
2026
Q1
$287K Sell
607
-42
-6% -$21.1K 0.02% 424
2025
Q4
$303K Sell
649
-4
-0.6% -$1.86K 0.02% 412
2025
Q3
$278K Sell
653
-7
-1% -$2.71K 0.02% 407
2025
Q2
$253K Buy
660
+3
+0.5% +$1.08K 0.01% 415
2025
Q1
$227K Sell
657
-15,369
-96% -$4.94M 0.02% 395
2024
Q4
$4.81M Buy
16,026
+12,739
+388% +$4.45M 0.3% 74
2024
Q3
$1.34M Buy
3,287
+88
+3% +$32.2K 0.09% 193
2024
Q2
$1.03M Sell
3,199
-2,126
-40% -$691K 0.07% 238
2024
Q1
$1.78M Sell
5,325
-1,761
-25% -$538K 0.13% 123
2023
Q4
$1.92M Sell
7,086
-3,402
-32% -$841K 0.13% 128
2023
Q3
$2.58M Buy
+10,488
New +$2.87M 0.17% 113

Other funds holding HCA

Summit Global Investments's HCA Position: Q2 2026 in Review

Summit Global Investments increased its HCA Healthcare (HCA) stake by 0.16% in Q2 2026, buying an estimated $423 and bringing the position to 608 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #494.

Summit Global Investments first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.81M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Summit Global Investments held 608 shares of HCA Healthcare worth $237K as of Q2 2026.
  • Summit Global Investments bought 1 HCA Healthcare share in Q2 2026, an estimated $423.
  • HCA Healthcare made up 0.01% of Summit Global Investments's portfolio in Q2 2026, its #494 holding.
  • Summit Global Investments first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Summit Global Investments's HCA Healthcare position peaked at $4.81M in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.